(Q40109458)

17 September 2017

title

Extrafine beclomethasone dipropionate/formoterol hydrofluoroalkane-propelled inhaler in asthma (English)

1 reference

17 September 2017

0 references

Alberto Papi

3

0 references

author name string

Pierluigi Paggiaro

series ordinal

1

1 reference

17 September 2017

Gabriele Nicolini

series ordinal

2

1 reference

17 September 2017

publication date

1 April 2008

1 reference

Expert Review of Respiratory Medicine

17 September 2017

published in

1 reference

17 September 2017

volume

2

1 reference

17 September 2017

issue

2

1 reference

17 September 2017

page(s)

161-166

1 reference

Inhaled salmeterol/fluticasone propionate: a review of its use in asthma

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.2.161

Budesonide/formoterol: a review of its use in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.2.161

Acute asthma intervention: insights from the STAY study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.2.161

Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.2.161

Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.2.161

One-year safety and efficacy of budesonide/formoterol in a single inhaler (Symbicort Turbuhaler) for the treatment of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.2.161

Formoterol (Foradil) and medium-high doses of inhaled corticosteroids are more effective than high doses of corticosteroids in moderate-to-severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.2.161

Beclometasone dipropionate/formoterol: in an HFA-propelled pressurised metered-dose inhaler.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.2.161

Advances in asthma and COPD management: delivering CFC-free inhaled therapy using Modulite technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.2.161

Biochemical interaction between effects of beclomethasone dipropionate and salbutamol or formoterol in sputum cells from mild to moderate asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.2.161

Anti-proliferative and anti-remodelling effect of beclomethasone dipropionate, formoterol and salbutamol alone or in combination in primary human bronchial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.2.161

Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.2.161

Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.2.161

Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.2.161

Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.2.161

Therapeutic significance of distal airway inflammation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.2.161

History and future perspectives of treating asthma as a systemic and small airways disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.2.161

Budesonide/formoterol: a review of its use as maintenance and reliever inhalation therapy in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.2.2.161

21 January 2018

Identifiers

DOI

10.1586/17476348.2.2.161

1 reference

17 September 2017

1 reference